Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMDANYSE:INFUNASDAQ:KRMDNASDAQ:LUNG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMDAAmedica$2.81-7.6%$0.26$0.18▼$6.40$33.36M-1.241.07 million shs5.47 million shsINFUInfuSystem$5.80-4.1%$5.31$4.61▼$9.97$121.89M1.7393,525 shs175,239 shsKRMDKORU Medical Systems$2.72-2.9%$2.63$1.86▼$5.05$125.50M0.39139,504 shs123,833 shsLUNGPulmonx$3.12-0.6%$5.17$3.06▼$9.37$125.61M0.65313,351 shs227,148 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMDAAmedica+0.66%-11.88%+70.79%-36.67%+3,229.68%INFUInfuSystem-4.13%-3.33%+20.83%-24.18%-22.77%KRMDKORU Medical Systems-2.86%-11.11%+12.40%-26.68%+21.97%LUNGPulmonx-0.64%-8.77%-34.45%-65.18%-65.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMDAAmedicaN/AN/AN/AN/AN/AN/AN/AN/AINFUInfuSystem2.444 of 5 stars2.00.00.00.02.94.21.9KRMDKORU Medical Systems2.3362 of 5 stars3.53.00.00.01.12.50.6LUNGPulmonx3.2504 of 5 stars4.33.00.00.02.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMDAAmedica 0.00N/AN/AN/AINFUInfuSystem 4.00Strong Buy$13.00124.14% UpsideKRMDKORU Medical Systems 3.00Buy$4.5065.44% UpsideLUNGPulmonx 2.67Moderate Buy$11.59271.57% UpsideCurrent Analyst Ratings BreakdownLatest AMDA, KRMD, INFU, and LUNG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2025LUNGPulmonxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.155/8/2025INFUInfuSystemB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.505/1/2025LUNGPulmonxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $15.005/1/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$10.00 ➝ $9.005/1/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$17.00 ➝ $17.003/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/13/2025KRMDKORU Medical SystemsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/10/2025LUNGPulmonxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy3/10/2025LUNGPulmonxMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight ➝ Equal Weight3/10/2025LUNGPulmonxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral ➝ Buy(Data available from 5/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMDAAmedica$11.23M2.97N/AN/A$1.80 per share1.56INFUInfuSystem$137.58M0.89$0.45 per share12.79$2.47 per share2.35KRMDKORU Medical Systems$35.08M3.58N/AN/A$0.45 per share6.04LUNGPulmonx$87.47M1.44N/AN/A$3.09 per share1.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMDAAmedica-$9.32M-$3.13N/AN/AN/A-139.62%-148.60%-67.83%N/AINFUInfuSystem$870K$0.1496.6818.71N/A1.12%2.78%1.41%N/AKRMDKORU Medical Systems-$13.74M-$0.11N/AN/AN/A-37.42%-24.60%-16.87%8/6/2025 (Estimated)LUNGPulmonx-$60.84M-$1.44N/AN/AN/A-67.31%-55.36%-33.53%7/30/2025 (Estimated)Latest AMDA, KRMD, INFU, and LUNG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 million5/7/2025Q1 2025LUNGPulmonx-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMDAAmedicaN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMDAAmedicaN/A1.110.99INFUInfuSystem0.501.981.59KRMDKORU Medical Systems0.012.992.37LUNGPulmonx0.407.706.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMDAAmedica3.72%INFUInfuSystem71.13%KRMDKORU Medical Systems58.60%LUNGPulmonx91.04%Insider OwnershipCompanyInsider OwnershipAMDAAmedica0.90%INFUInfuSystem11.40%KRMDKORU Medical Systems20.60%LUNGPulmonx6.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMDAAmedicaN/A11.87 millionN/ANot OptionableINFUInfuSystem41021.02 million19.10 millionOptionableKRMDKORU Medical Systems8046.14 million34.10 millionOptionableLUNGPulmonx25040.26 million37.24 millionOptionableAMDA, KRMD, INFU, and LUNG HeadlinesRecent News About These CompaniesPulmonx Co. (NASDAQ:LUNG) Shares Sold by Jacobs Levy Equity Management Inc.May 20 at 4:38 AM | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives $12.07 Consensus Price Target from AnalystsMay 20 at 2:23 AM | americanbankingnews.comPulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of "Moderate Buy" by BrokeragesMay 19, 2025 | marketbeat.com82,070 Shares in Pulmonx Co. (NASDAQ:LUNG) Purchased by Mercer Global Advisors Inc. ADVMay 15, 2025 | marketbeat.comWhy Pulmonx Corporation’s (LUNG) Stock Is Down 5.82%May 10, 2025 | aaii.comDeerfield Management Company L.P. Series C Purchases New Position in Pulmonx Co. (NASDAQ:LUNG)May 10, 2025 | marketbeat.comIt’s Time to Recognize COPD as a Women’s Health IssueMay 8, 2025 | medscape.comPulmonx Corporation (NASDAQ:LUNG) Q1 2025 Earnings Call TranscriptMay 6, 2025 | msn.comD. Boral Capital Reaffirms Buy Rating for Pulmonx (NASDAQ:LUNG)May 3, 2025 | marketbeat.comPulmonx (LUNG) Expected to Announce Quarterly Earnings on WednesdayMay 2, 2025 | marketbeat.comPulmonx to Present at the Bank of America Securities 2025 Health Care ConferenceMay 1, 2025 | globenewswire.comQ1 2025 Pulmonx Corp Earnings CallMay 1, 2025 | finance.yahoo.comBoothbay Fund Management LLC Sells 63,206 Shares of Pulmonx Co. (NASDAQ:LUNG)May 1, 2025 | marketbeat.comPulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ...May 1, 2025 | uk.finance.yahoo.comPulmonx projects 20% long-term growth amid expanded initiatives and $12B market opportunityMay 1, 2025 | msn.comPulmonx Corporation (LUNG) Q1 2025 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comPulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue EstimatesApril 30, 2025 | zacks.comPulmonx Reports First Quarter 2025 Financial ResultsApril 30, 2025 | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Shares Purchased by Renaissance Technologies LLCApril 30, 2025 | marketbeat.comPulmonx's Earnings OutlookApril 29, 2025 | benzinga.comBirchview Capital LP Purchases Shares of 51,000 Pulmonx Co. (NASDAQ:LUNG)April 28, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMDA, KRMD, INFU, and LUNG Company DescriptionsAmedica NASDAQ:AMDASINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.InfuSystem NYSE:INFU$5.80 -0.25 (-4.13%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$5.80 +0.00 (+0.09%) As of 05/22/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.KORU Medical Systems NASDAQ:KRMD$2.72 -0.08 (-2.86%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$2.71 -0.01 (-0.37%) As of 05/22/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Pulmonx NASDAQ:LUNG$3.12 -0.02 (-0.64%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$3.29 +0.17 (+5.58%) As of 06:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1 Cathie Wood Just Bought a New Stake in Taiwan Semiconductor Stock Super Micro Computer Stock Clears New Path Higher on Saudi Orders Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith? Why Carnival Could Be the Ultimate Non-Tech Growth Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
